Morning Overview on MSN
Early trial shows pancreatic cancer mRNA vaccine responses lasting 6 years
Six years after surgery for one of the deadliest cancers in medicine, a small group of patients who received a personalized ...
A newly proposed model suggests cancer cells may resist treatment not just through genetic mutations, but by dynamically ...
New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...
Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest ...
Researchers have pinpointed what could be the early genetic origins of breast cancer -- cancer-like mutations appearing in the cells of healthy women. In a new study, the international collaborators ...
Cancer cells are known for their “glutamine addiction,” but many can escape this weakness by switching to alternative fuels.
A Phase 3 trial found daraxonrasib nearly doubled survival in advanced pancreatic cancer, offering new hope ahead of FDA ...
BREAST CANCER SURGERY. ACCORDING TO A GENETIC COUNSELOR AT MERCY MEDICAL CENTER, YOUR CHANCE OF DEVELOPING BREAST CANCER WITHOUT A FAMILY HISTORY OR NO OTHER SPECIAL CIRCUMSTANCE IS ABOUT 12%. THE ...
Michele Carbone and Haining Yang, professors at University of Hawaiʻi Cancer Center, are recipients of the prestigious V ...
New research suggests that autoimmune diseases may be driven by DNA mutations in immune cells that remove the natural brakes ...
A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results